PALATIN TECHNOLOGIES INC COM USD0.01 (POST REV SPLIT)PALATIN TECHNOLOGIES INC COM USD0.01 (POST REV SPLIT)PALATIN TECHNOLOGIES INC COM USD0.01 (POST REV SPLIT)

PALATIN TECHNOLOGIES INC COM USD0.01 (POST REV SPLIT)

No trades
See on Supercharts

0KF3 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

0KF3 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company